112949 ⎘
Oligonucleotides characterized by their use Screening for pharmacological compounds
MODULATION OF TRANSTHYRETIN EXPRESSION
#602MODULATION OF TRANSTHYRETIN EXPRESSION
#603MODULATION OF TRANSTHYRETIN EXPRESSION
#604MODULATION OF TRANSTHYRETIN EXPRESSION
#605MODULATION OF TRANSTHYRETIN EXPRESSION
#606MODULATION OF TRANSTHYRETIN EXPRESSION
#607Methods of using compositions comprising variants of FGF19 polypeptides for treating primary biliary cirrhosis in a subject
#608Allogeneic autophagosome-enriched composition for the treatment of disease
#609DISTINGUISHING PCA3 MESSENGER RNA SPECIES IN BENIGN AND MALIGNANT PROSTATE TISSUES
#610Genetic polymorphisms associated with autoinflammatory diseases, methods of detection and uses thereof
#611Selective reduction of the deleterious activity of extended tri-nucleotide repeat containing genes
#612Breast cancer biomarkers and methods of using same
#613TRANSCRIPTOMIC BIOMARKER OF MYOCARDITIS
#614METHODS FOR TREATMENT OF CARDIOVASCULAR DISEASE
#615METHODS OF TREATING LUNG CANCER BY ADMINISTRATION OF AN ALK INHIBITOR
#616Assay system to identify HPV replication inhibitors in HT-screen
#617METHOD FOR MAINTAINING INCREASED INTRACELLULAR p53 LEVEL, INDUCED BY PLATINUM-BASED ANTICANCER DRUG, AND APPLICATION THEREOF
#618Treatment and diagnosis of melanoma
#619Method for Evaluating the Harmful Effects of Urine on Children's Skin
#620GENETIC ALTERATIONS ASSOCIATED WITH AUTISM AND THE AUTISTIC PHENOTYPE AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF AUTISM
#621TUMOR ANTIGEN PEPTIDE
#622MODULATION OF ANGIOPOIETIN-LIKE 3 EXPRESSION
#623Oligodeoxy nucleotide for preparing drugs for inhibiting tumor growth and application thereof
#624Pancreatic stromal progenitor cells
#625Oligodeoxy nucleotide for preparing drugs for inhibiting tumor growth and application thereof
#626Oligodeoxy nucleotide for preparing drugs for inhibiting tumor growth and application thereof
#627Fluorescent probes for abasic site detection
#628Diagnosis and treatment of genetic alterations associated with eosinophilic esophagitis
#629ANTI-INFLAMMATORY AGENTS
#630Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
#631Composition for inhibiting growth or proliferation of chronic myelogenous leukemia cancer stem cells, and screening method therefor
#632SCREENING ASSAYS BASED ON MAG AND/OR ABHD6 FOR SELECTING INSULIN SECRETION PROMOTING AGENT
#633CRISPR mediated in vivo modeling and genetic screening of tumor growth and metastasis
#634MICRORNA EXPRESSION PROFILE ASSOCIATED WITH PANCREATIC CANCER
#635Diagnostic and screening methods for atopic dermatitis
#636Method for diagnosing and treating ovarian cancer
#637METHODS, TOOLS AND SYSTEMS FOR THE ASSESSMENT, PREVENTION, MANAGEMENT AND TREATMENT SELECTION FOR TYPE 2 DIABETES
#638COMPETITIVE MODULATION OF MICRORNAS
#639Methods to analyze genetic alterations in cancer to identify therapeutic peptide vaccines and kits therefore
#640Use of Tetraspanin-2 for Treating Diabetes and Screening an Anti-diabetic agent
#641SAB as a biomarker for degenerative diseases and therapeutic sensitivity in cancers
#642CANCER MARKER AND THE USE THEREOF
#643DNA conformation (loop structures) in normal and abnormal gene expression
#644Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling
#645METHOD FOR PREDICTING RESPONSIVENESS TO PHOSPHATIDYLSERINE SYNTHASE 1 INHIBITOR
#646APOBEC3A CYTIDINE DEAMINASE INDUCED RNA EDITING
#647Treatment of interferon regulatory factor 8 (IRF8) related diseases by inhibition of natural antisense transcript to IRF8
#648RNA products and uses thereof
#649miRNA modulators of thermogenesis
#650COMPOSITIONS AND METHODS OF IDENTIFYING TUMOR SPECIFIC NEOANTIGENS
#651PROSTATE CANCER SURVIVAL AND RECURRENCE
#652METHOD OF DIAGNOSIS, PROGNOSIS OR TREATMENT OF NEURODEGENERATIVE DISEASES
#653METHOD OF TREATING HEPATITIS B
#654COMPOSITION FOR DIAGNOSING SKIN DAMAGE CAUSED BY FINE DUST, AND COMPOSITION COMPRISING GALANGIN AS ACTIVE INGREDIENT
#655Methods and compositions for identifying pathogenic vibrio parahaemolyticus
#656Antisense nucleic acids
#657TARGETING GDF6 AND BMP SIGNALING FOR ANTI-MELANOMA THERAPY
#658CKAP4-molecular-targeted antitumor agent
#659STRAIN OF LACTOBACILLUS ACIDOPHILUS HAVING ANALGESIC PROPERTIES IN THE GASTROINTESTINAL SYSTEM
#660METHOD FOR PREDICTING SENSITIVITY TO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR INHIBITOR
#661PUMA, A PRO-APOPTOTIC GENE, AS A NOVEL MOLECULAR BIOMARKER FOR TNFALPHA-INDUCED HUMAN ISLET DAMAGE
#662Gene and mutations thereof associated with seizure and movement disorders
#663Acyl-amino-LNA and/or hydrocarbyl-amino-LNA oligonucleotides
#664Screening method
#665Articles for diagnosis of liver fibrosis
#666Employing human adipose-derived stem cells to propagate serum-derived hepatitis C virus and use thereof
#667Markers of acute myeloid leukemia stem cells
#668Biological Materials and Uses Thereof
#669Production of midbrain dopaminergic neurons and methods for the use thereof
#670Methods and materials for assessing chemotherapy responsiveness and treating cancer
#671Novel Therapeutic Agent for Septicemia, and a Method for Screening for Same
#672GENETIC VARIANT OF THE ANNEXIN A5 GENE
#673Biomarkers for inflammatory bowel disease
#674Biomarkers for inflammatory bowel disease
#675Editing profiling of PDE8A pre-mRNA: use as specific biomarker of ADARs activities in human tissues to diagnose and to predict and assess therapeutic efficacy and/or efficiency or potential drug side effects
#676Treatment of erythropoietin (EPO) related diseases by inhibition of natural antisense transcript to EPO
#677BCR-ABL variants
#678Method of predicting a predisposition to QT prolongation
#679Method of predicting a predisposition to QT prolongation
#680TRANSCRIPTION FACTOR DECOYS, COMPOSITIONS AND METHODS
#681Screening method for pain suppressor and pharmaceutical composition for prevention or treatment of pain
#682TREATMENT OF HUTCHINSON-GILFORD PROGERIA SYNDROME AND DISEASES RELATED TO VASCULAR AGEING
#683Method for identification of anti-HIV human miRNA mimics and miRNA inhibitors and anti-HIV pharmaceutical compounds
#684METHODS AND REAGENTS FOR TREATMENT OF AGE-RELATED MACULAR DEGENERATION
#685IDENTIFICATION OF CELLULAR ANTIMICROBIAL DRUG TABLETS THROUGH INTERACTOME ANALYSIS
#686Methods of treating and prognosing nonhematopoietic malignant tumors
#687Simultaneous detection of cannibalism and senescence as prognostic marker for cancer
#688Treatment of angiogenesis disorders
#689Methods of predicting clinical course and treating multiple sclerosis
#690miRNA-based universal screening test (UST)
#691Tumor antigen peptide
#692Rationale, methods, and assays for identifying human and non-human primate taste specific genes and use thereof in taste modulator and therapeutic screening assays
#693ACTIVITY-DEPENDENT GENE PAIRS AS THERAPEUTIC TARGETS AND METHODS AND DEVICES TO IDENTIFY THE SAME
#694METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING DISEASES
#695Cell identification method
#696Drug efficacy test method for dementias utilizing astrocyte-derived exosomes
#697METHOD FOR SCREENING FOR BIOACTIVE NATURAL PRODUCTS
#698METASTASIS SPECIFIC SPLICE VARIANTS OF MENA AND USES THEREOF IN DIAGNOSIS, PROGNOSIS AND TREATMENT OF TUMORS
#699Inhibitors of cell adhesion
#700Polymorphism in the Apo(a) gene predict responsiveness to acetylsalicylic acid treatment
#701Identification and use of novopeptides for the treatment of cancer
#702EXPRESSION AND FUNCTION OF GPR64/ADGRG2 IN ENDOCRINE SYSTEMS AND METHODS TO TARGET IT THERAPEUTICALLY
#703MIPOL1-ETV1 gene rearrangements
#704Breast cancer susceptibility gene GT198 and uses thereof
#705Methods of predicting toxicity
#706Core transcriptional circuitry in human cells and methods of use thereof
#707RECOMBINANT HBV CCCDNA, THE METHOD TO GENERATE THEREOF AND THE USE THEREOF
#708Integrated compound discovery systems and methods
#709Method of identifying cosmetic agents for moisturizing skin
#710Modulators of ACYL-COA lysocardiolipin acyltransferase 1 (ALCAT1) and uses thereof
#711Methods of selecting T cell line and donor thereof for adoptive cellular therapy
#712Treatment and diagnosis of melanoma
#713SLFN11 AS BIOMARKER FOR AML
#714Compositions and methods for treating malignancies
#715BCR-ABL1 splice variants and uses thereof
#716BIOMARKER FOR DIAGNOSIS OF AGING OR AMYOTROPHIA
#717Methods for characterizing alternatively or aberrantly spliced mRNA isoforms
#718Methods of modulating immune system responses
#719SIGNATURES AND PCDETERMINANTS ASSOCIATED WITH PROSTATE CANCER AND METHODS OF USE THEREOF
#720Nucleic acids related to MiR-29B-1-5P and uses thereof
#721MATERIALS AND METHODS FOR IMPROVING THE EFFECTIVENESS OF IMMUNOMODULATORY CANCER THERAPY AND RELATED METHODOLOGIES
#722ANTI-TUMOR THERAPY
#723Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof
#724Methods of Treatment
#725Compositions and methods for enhancing odorant receptor activity
#726DESIGN OF NUCLEIC ACID BINDING MOLECULES WITH NON-WATSON CRICK AND NON-CANONICAL PAIRING BASED ON ARTIFICIAL MUTATION CONSENSUS SEQUENCES TO COUNTER ESCAPE MUTATIONS
#727Use of sting agonists to treat chronic hepatitis B virus infection
#728SYSTEM, METHOD AND SOFTWARE FOR ROBUST TRANSCRIPTOMIC DATA ANALYSIS
#729Markers for breast cancer
#730ALK AND ROS KINASE IN CANCER
#731Methods of detecting prostate cancer
#732Methods Of Inhibiting Tumorigenesis In Colon Adenocarcinoma And Compositions Therefor
#733Methods of Detecting Diseases or Conditions Using Phagocytic Cells
#734Peptides and combination of peptides for use in immunotherapy against cancers
#735POLYNUCLEOTIDES AND POLYPEPTIDE SEQUENCES INVOLVED IN THE PROCESS OF BONE REMODELING
#736Uterine cancer treatments
#737Target of VGSC β3 protein for prevention, treatment and diagnostic detection of cancers
#738ANGIOPOITEN-2 BIOMARKERS PREDICTIVE OF ANTI-IMMUNE CHECKPOINT RESPONSE
#739COMPOSITIONS, METHODS AND USE OF SYNTHETIC LETHAL SCREENING
#740METHODS FOR TREATING SOLID TUMORS AND THE USE OF BIOMARKERS AS A PREDICTOR OF CLINICAL SENSITIVITY TO IMMUNOMODULATORY THERAPIES
#741Method for evaluating the harmful effects of urine on children's skin
#742DISEASE SUSCEPTIBILITY
#743Modulation of breast cancer growth by modulation of XBP1 activity
#744VITAMIN K EPOXIDE RECYCLING POLYPEPTIDE VKORC1, A THERAPEUTIC TARGET OF COUMARIN AND THEIR DERIVATIVES
#745Compositions and methods for therapeutics prescreening
#746MicroRNAs characterizing rosacea and the uses thereof
#747Compositions Comprising Small Interfering RNA Molecules for Prevention and Treatment of Ebola Virus Disease
#748Methods and compositions for T cell generation and uses thereof
#749Micrornas characterizing acne and the uses thereof
#750Methods for identifying subjects with a genetic risk for developing IgA nephropathy
#751Dynamic flux nucleic acid sequence amplification
#752Method for improving memory using CCNY inhibitor
#753IDENTIFICATION OF IMMUNOLOGICALLY PROTECTIVE NEO-EPITOPES FOR THE TREATMENT OF CANCERS
#754PANCREATIC CANCER TARGETS AND USES THEREOF
#755DRUG DISCOVERY METHODS USING PLANT DEVELOPMENTAL BIOLOGY
#756Influenza A virus variants
#757Influenza A virus variants
#758Methods and compositions for detecting gastrointestinal and other cancers
#759USE OF H2A.Z.1 AS A HEPATOCELLULAR CARCINOMA BIOMARKER
#760Antisense nucleic acids
#761Quinoline derivatives for the treatment of inflammatory diseases
#762Methods for treating cancer and the use of biomarkers as a predictor of clinical sensitivity to therapies
#763METHODS AND COMPOSITIONS FOR DETERMINING RESISTANCE TO ANDROGEN RECEPTOR THERAPY
#764Biomarkers for human monocyte myeloid-derived suppresor cells
#765Transcription biomarkers of biological responses and methods of use
#766TISSUE MOLECULAR SIGNATURES OF KIDNEY TRANSPLANT REJECTION
#767RNA EDITING BIOMARKERS FOR DIAGNOSIS, PHARMACOLOGICAL SCREENING AND PROGNOSTICATION IN CANCER
#768Method for preparation of retinal ganglion cells
#769G protein coupled receptor 85 and SREB3 knockout mice and uses thereof
#770P13K-MTORC1-S6K1 signaling pathway biomarkers predictive of anti-cancer responses
#771Molecular signatures for distinguishing liver transplant rejections or injuries
#772METHODS AND COMPOSITIONS FOR RISK PREDICTION, DIAGNOSIS, PROGNOSIS, AND TREATMENT OF PULMONARY DISORDERS
#773Use of double-stranded DNA in exosomes: a novel biomarker in cancer detection
#774METHODS FOR DIAGNOSING AND TREATING NEUROIMMUNE-BASED PSYCHIATRIC DISORDERS
#775In vitro assays for assessing cell aging
#776Methods and systems for determining oncogenic index of patient specific mutations
#777Methods for determining drug response of patient specific mutations
#778METHODS FOR DETECTING TELOMERE MAINTENANCE MECHANISMS
#779METHODS OF ESTIMATING LOGD OF TAGGED COMBINATORIAL LIBRARY COMPOUNDS
#780Composition, kit, and method for diagnosing and treating ovarian cancer
#781Lung cancer markers and uses thereof
#782Cellular discovery platform for neurodegenerative diseases
#783Methods and systems for determination of an effective therapeutic regimen and drug discovery
#784Therapeutic agent for emphysema and COPD
#785USE OF ACTIVIN RECEPTOR-LIKE KINASE 1 (ALK-1) ANTAGONISTS IN THE TREATMENT OF CANCER
#786Genetic polymorphisms, associated with rheumatoid arthritis, methods of detection and uses thereof
#787Treatment of nuclear factor (erythroid-derived 2)-like 2 (NRF2) related diseases by inhibition of natural antisense transcript to NRF2
#788Identification of cancer protein biomarkers using proteomic techniques
#789Tumor suppressor and oncogene biomarkers predictive of anti-immune checkpoint inhibitor response
#790INTERFERON ALPHA-INDUCED PHARMACODYNAMIC MARKERS AND USES THEREOF
#791Detoxification of microbial virulence factors in oral cavity
#792Activating JAK Kinase Biomarkers Predictive of Anti-Immune Checkpoint Inhibitor Response
#793Compositions and methods for targeting cancer-specific sequence variations
#794Pluripotent cell lines and methods of use thereof
#795Array and Method of Use
#796Methods of using miRNA from bodily fluids for early detection and monitoring of mild cognitive impairment (MCI) and Alzheimer's disease (AD)
#797Modulation of growth hormone receptor expression and insulin-like growth factor expression
#798Methods of cancer therapy by inhibiting fusion polypeptides comprising fibroblast growth factor receptor 2 (FGFR2) and vinculin (VCL)
#799NOL3 is a predictor of patient outcome
#800Modulation of gene expression and screening for deregulated protein expression
#801METHODS AND COMPOSITIONS FOR CALICIVIRIDAE
#802Methods for Inhibiting Epithelial to Mesenchymal Transition by Inhibition of FOXS1
#803Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma
#804COVALENTLY BOUND METABOLITES AS BIOMARKERS
#805Methods for modulating KLHL1 levels, methods for modulating current activity in T-type calcium channels, molecules therefor, and methods for identifying molecules therefor
#806Production of fertile XY female animals by silencing of genes on the Y chromosome
#807Gene expression markers of tumor resistance to HER2 inhibitor treatment
#808Method for screening agents promoting skin barrier function and method for evaluating skin barrier function taking epidermal serine racemase and/or D-serine level as indicator
#809Diagnostic for Sepsis
#810INFLAMMATION-ENABLING POLYPEPTIDES AND USES THEREOF
#811Method for predicting responsiveness to cancer treatment using p300-inhibiting compound
#812Nuclear localization of Src-family tyrosine kinases is required for growth factor-induced euchromatinization
#813Skin and hair color-controlling factor
#814Polypeptides and Antibodies for Assessing Predisposition for Myelodysplastic Syndromes or Myelogenous Tumor, and Method for Screening Therapeutic Drugs Therefor
#815Methods Employing Non-Coding RNA Expression Assays
#816Compounds that modulate oxidative stress
#817Specific and high affinity binding proteins comprising modified SH3 domains of Fyn kinase
#818Compositions and methods for identification, assessment, prevention, and treatment of cancer using NFS1 biomarkers and modulators
#819EXTRACELLULAR VESICLE METHODS AND COMPOSITIONS
#820Method for treating cell proliferation related disorders
#821Methods of Detecting Diseases or Conditions Using Phagocytic Cells
#822Method for diagnosing hepatic fibrosis
#823Genetic alterations on chromosome 16 and methods of use thereof for the diagnosis and treatment of type 1 diabetes
#824REACTIVATION OF X CHROMOSOME GENES
#825Detection of Niemann-Pick disease comprising detection of lysozyme and cathepsins
#826Polycomb-associated non-coding RNAs
#827Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
#828Biomarkers of osteoarthritis
#829Materials and methods for diagnosing and predicting the course of prostate cancer
#830Generalizable assay for virus capsid assembly
#831Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
#832CaMKK-β as a target for treating cancer
#833High MAST2-affinity polypeptides and uses thereof
#834Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
#835Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof
#836Polycomb-associated non-coding RNAs
#837Methods of modulating WARS2
#838Avian influenza virus miRNA, and appraisal, detection, and application thereof
#839SCREENING TARGETS AND COMPOSITIONS AND METHODS FOR TREATMENT OF CILIOPATHY DISORDERS
#840METHOD OF TREATING AND REDUCING THE RISK OF ACUTE MYELOGENOUS LEUKEMIA
#841Neoantigen treatment prioritization using multivariate analysis based on: HLA genotype, self-similarity, similarity to known antigens, antigen expression levels and mutant allele frequency
#842METHOD FOR TESTING FOR AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE AND METHOD FOR SCREENING AGENT FOR TREATMENT OF THE DISEASE
#843Composition for promoting chondrocyte differentiation or treating cartilage diseases, containing KLF10 expression inhibitor, and method for promoting cartilage differentiation by using same
#844Sumoylation of SERCA2a and cardiovascular disease
#845Methods of treating or preventing pruritis by blocking natriuretic polypeptide B
#846KIF5B-RET fusion molecules and uses thereof
#847METHOD FOR SCREENING THERAPEUTIC AND/OR PROPHYLACTIC AGENTS FOR ALZHEIMER'S DISEASE
#848Eye disease treatment agent, screening method therefor, and method for predicting rejection response associated with retinal pigment epithelial cell transplant
#849Methods to diagnose and treat attention-deficit, hyperactivity disorder (ADHD)
#850METHODS AND KITS USED IN IDENTIFYING MICRORNA TARGETS
#851EGFR/NEDD9/TGF-β interactome and methods of use thereof for the identification of agents having efficacy in the treatment of hyperproliferative disorders
#852MiRNA modulators of thermogenesis
#853Methods and Compositions for Inhibiting Mitochondrial Trafficking
#854TRPC6 involved in glomerulonephritis
#855Biomarkers for premature birth and use thereof
#856Polycomb-associated non-coding RNAS
#857Methods of Manipulating the Fate of Cells
#858Biomarkers for gastric cancer and uses thereof
#859Molecular marker for cancer stem cell
#860SIGNATURES AND DETERMINANTS ASSOCIATED WITH PROSTATE CANCER PROGRESSION AND METHODS OF USE THEREOF
#861Cedar virus and methods of use
#862DIFFERENTIALLY EXPRESSED MICRORNA MOLECULES FOR THE TREATMENT AND DIAGNOSIS OF CANCER
#863Polycomb-associated non-coding RNAs
#864Polycomb-associated non-coding RNAs
#865Compositions and methods for modulating an immune response
#866Venule endothelial cell genes and uses thereof
#867Schlap-1 ncRNA and uses thereof
#868CXCR4 as a susceptibility locus in juvenile idiopathic arthritis (JIA) and methods of use thereof for the treatment and diagnosis of the same
#869METHOD FOR EVALUATING THE EFFECTS OF A COMPOSITION COMPRISING MICROORGANISMS ON INTESTINAL MICROBIOTA
#870MODULATION OF TRANSTHYRETIN EXPRESSION
#871In Vitro Pharmacokinetics/Pharmacodynamics Bellows Perfusion System for Enhancing Effectiveness of Cancer Chemotherapy
#872Anticancer adjuvant composition containing RIP3 expression promoter as active ingredient, method for screening for anticancer adjuvant enhancing sensitivity of anticancer drug by promoting RIP3 expression, and method for monitoring sensitivity of anticancer drug
#873Methods and kits to predict therapeutic outcome of BTK inhibitors
#874Methods of diagnosing bipolar disorders and screening for therapeutic compounds
#875Treatment of vascular endothelial growth factor (VEGF) related diseases by inhibition of natural antisense transcript to VEGF
#876COMPOSITIONS AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF MELANOMA USING PD-L1 ISOFORMS
#877METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMAS
#878Knock-in rodent comprising a mutation in an endogenous CRBN locus and methods of use thereof
#879Method of diagnosis, prognostic or treatment of neurodegenerative disease
#880Alternative splicing variant of OATP1B3 mRNA
#881MOLECULAR SIGNATURES OF CONDITIONS ASSOCIATED WITH LONGEVITY
#882Treatment and diagnosis of melanoma
#883Detection of oral microbial virulence factors
#884Prophylactic and therapeutic agents for FGFR3 diseases and screening method for the same
#885Compositions and methods for diagnosing, evaluating and treating cancer
#886Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer
#887INFLAMMATION-ENABLING POLYPEPTIDES AND USES THEREOF
#888ANTI-VIRAL THERAPY
#889Pathogenesis quantification systems and treatment methods for citrus greening blight
#890Recurrent gene fusions in prostate cancer
#891A Method for Identification of Anti-HIV Human miRNA Mimics and miRNA Inhibitors and Anti-HIV Pharmaceutical Compounds
#892MicroRNAs and uses thereof
#893Non-coding RNA of and identification and use thereof
#894COMPOSITION FOR PREVENTING OR TREATING OSTEOPOROSIS, CONTAINING PROGRANULIN INHIBITOR AS ACTIVE INGREDIENT
#895Use of miR-494 to Modulate TRAIL-induced Apoptosis through BIM Down-regulation
#896Methods and compositions for treating cancer using peptide nucleic acid-based agents
#897NOVEL FUSION GENES AS FACTORS RESPONSIBLE FOR GASTRIC CANCER
#898METHODS FOR DETERMINING DRUG EFFICACY FOR THE TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA, MULTIPLE MYELOMA, AND MYELOID CANCERS
#899SINGLE CELL GENE EXPRESSION FOR DIAGNOSIS, PROGNOSIS AND IDENTIFICATION OF DRUG TARGETS
#900Use and identification of biomarkers for gastrointestinal diseases